한글목차

세계의 산모 정신건강 시장은 2024년에는 58억 3,000만 달러로 평가되었고, 2030년에는 CAGR 9.23%로 확대될 전망이며, 새로운 성장 수준에 도달할 것으로 예측되고 있습니다.

산모 정신건강은 산후 우울증, 불안 장애, PTSD 등의 증상을 포함하여 공중 보건 우선 순위로 점점 인식되고 있습니다. 이러한 정신위생상의 과제는 임신 중이나 산욕기에 생길 수 있으며 조산 및 발달상의 문제 등 모자 모두에게 심각한 영향을 미칩니다. 의식의 고조, 도움을 요청하는 것의 정상화, 정신건강 관리 서비스에 대한 접근성 개선이 시장의 성장에 기여하고 있습니다. 게다가 헬스케어 공급자나 정책 입안자는, 보다 포괄적인 스크리닝이나 치료 전략을 도입하고 있습니다. 모바일 헬스 앱, 웨어러블 모니터링 디바이스, AI를 활용한 분석 등의 기술적 진보도 조기 발견과 개별화 개입에 매우 중요한 역할을 하고 있습니다. 세계 출산율 상승은 의식의 고조 및 지원 인프라와 맞물려 산모 정신건강 시장에 있어서 향후 수년간의 견조한 성장을 촉진할 것으로 예상됩니다.

시장 성장 촉진요인

산모 정신건강 질환의 높은 유병률이 세계 산모 정신건강 시장 견인

주요 시장 과제

스티그마 및 인지도

주요 시장 동향

기술 진보

목차

제1장 개요

제2장 조사 방법

제3장 주요 요약

제4장 고객의 목소리

제5장 세계의 산모 정신건강 시장 전망

• 시장 규모 및 예측
  • 금액별
• 시장 점유율 및 예측
  • 질환별(산후 우울증, 기분 변조증, 임신 및 산후 전반 불안증, 임신 및 산후 강박성 장애, 출산 관련 PTSD, 기타)
  • 요법(대인관계요법, 항우울제, 인지행동요법 등)
  • 지역별
  • 기업별(2024년)
• 시장 맵

제6장 북미의 산모 정신건강 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 북미 : 국가별 분석
  • 미국
  • 캐나다
  • 멕시코

제7장 유럽의 산모 정신건강 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 유럽 : 국가별 분석
  • 독일
  • 영국
  • 이탈리아
  • 프랑스
  • 스페인

제8장 아시아태평양의 산모 정신건강 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 아시아태평양 : 국가별 분석
  • 중국
  • 인도
  • 일본
  • 한국
  • 호주

제9장 남미의 산모 정신건강 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 남미 : 국가별 분석
  • 브라질
  • 아르헨티나
  • 콜롬비아

제10장 중동 및 아프리카의 산모 정신건강 시장 전망

• 시장 규모 및 예측
• 시장 점유율 및 예측
• 중동 및 아프리카 : 국가별 분석
  • 남아프리카
  • 사우디아라비아
  • 아랍에미리트(UAE)

제11장 시장 역학

• 성장 촉진요인
• 과제

제12장 시장 동향 및 발전

• 합병 및 인수
• 제품 개발
• 최근 동향

제13장 세계의 산모 정신건강 시장 : SWOT 분석

제14장 경쟁 구도

• Therapy Mama
• Canopie
• Pfizer Inc
• Viatris Inc.
• GlaxoSmithKline Inc.
• Alembic Pharmaceuticals Limited
• Mallinckrodt Inc.
• Sage Therapeutics, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

제15장 전략적 제안

제16장 기업 소개와 및 면책사항

영문목차

The Global Maternal Mental Health Market was valued at USD 5.83 billion in 2024 and is projected to reach new growth levels by 2030, expanding at a CAGR of 9.23%. Maternal mental health, encompassing conditions such as postpartum depression, anxiety, and PTSD, is increasingly recognized as a public health priority. These mental health challenges can arise during pregnancy or the postpartum period and have serious implications for both mother and child, including premature birth and developmental issues. Rising awareness, the normalization of seeking help, and improved access to mental healthcare services are contributing to the market's growth. Additionally, healthcare providers and policy makers are implementing more comprehensive screening and treatment strategies. Technological advancements, including mobile health apps, wearable monitoring devices, and AI-powered analytics, are also playing a pivotal role in early detection and personalized intervention. The increasing global birth rate, coupled with heightened awareness and support infrastructure, is expected to fuel robust growth in the maternal mental health market over the coming years.

Key Market Drivers

High Prevalence of Maternal Mental Health Disorders is Driving Global Maternal Mental Health Market

The increasing recognition of the prevalence and impact of perinatal mental health disorders is a primary driver for the market. Conditions such as postpartum depression, general anxiety, and PTSD are now known to affect a substantial proportion of women during and after pregnancy. Studies indicate that up to one in seven women in the U.S. experience postpartum depression, with other regions reflecting similarly high rates. The COVID-19 pandemic further intensified maternal mental health concerns, with research from the University of Michigan highlighting that nearly one in three mothers during early 2020 experienced symptoms of depression. This growing awareness has encouraged greater demand for mental health services tailored specifically to the maternal population. Healthcare systems, non-profits, and governments are increasingly supporting maternal mental health programs, while tech firms and pharmaceutical companies are innovating around treatment and support tools, further driving market expansion.

Key Market Challenges

Stigma and Awareness

One of the major obstacles hindering market growth is the persistent stigma surrounding mental health during and after pregnancy. Many women feel pressured to conform to societal expectations that motherhood should be a purely joyful experience, leading to feelings of guilt or fear of judgment if they disclose emotional distress. As a result, many mothers delay or avoid seeking treatment altogether. Compounding this issue is the lack of consistent mental health screening in prenatal and postpartum care. To combat these barriers, efforts must focus on awareness campaigns, caregiver training, and integration of mental health checks into routine maternal care. Destigmatizing maternal mental health through education and supportive community platforms remains essential to unlocking further growth in the market.

Key Market Trends

Technological Advancements

Technology is playing a transformative role in the maternal mental health market. The rise of telehealth has made it easier for women to access care from the safety and privacy of their homes. Mobile apps designed for mood tracking, meditation, and personalized support are becoming more prevalent, offering scalable and accessible mental health solutions. Wearable technologies also support continuous monitoring of vital signs and stress indicators, enabling early detection of mental distress. Artificial Intelligence is being used to analyze behavioral and physiological data, helping predict mental health risks and guide timely interventions. Moreover, Virtual Reality is emerging as a therapeutic tool for treating postpartum anxiety and PTSD by offering immersive relaxation and exposure therapy experiences. Collectively, these technological developments are helping to reduce barriers to care, improve treatment personalization, and enhance patient engagement.

Key Market Players

• Therapy Mama
• Canopie
• Pfizer Inc
• Viatris Inc.
• GlaxoSmithKline Inc.
• Alembic Pharmaceuticals Limited
• Mallinckrodt Inc.
• Sage Therapeutics, Inc.
• Bausch Health Companies Inc.
• Magellan Health, Inc.

Report Scope:

In this report, the Global Maternal Mental Health Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Maternal Mental Health Market, By Disease Indication:

• Postpartum Depression
• Dysthymia
• Pregnancy and Postpartum General Anxiety
• Pregnancy and Postpartum OCD
• Birth-Related PTSD
• Others

Maternal Mental Health Market, By Therapy:

• Interpersonal Psychotherapy
• Antidepressants
• Cognitive Behavioral Therapy
• Others

Maternal Mental Health Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • France
  • United Kingdom
  • Italy
  • Germany
  • Spain
• Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Maternal Mental Health Market.

Available Customizations:

Global Maternal Mental Health market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

4. Voice of Customer

5. Global Maternal Mental Health Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Disease Indication (Postpartum Depression, Dysthymia, Pregnancy and Postpartum General Anxiety, Pregnancy and Postpartum OCD, Birth-Related PTSD, Others)
  • 5.2.2. By Therapy (Interpersonal Psychotherapy, Antidepressants, Cognitive Behavioral Therapy, others)
  • 5.2.3. By Region
  • 5.2.4. By Company (2024)
• 5.3. Market Map

6. North America Maternal Mental Health Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Disease Indication
  • 6.2.2. By Therapy
  • 6.2.3. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Maternal Mental Health Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Disease Indication
      • 6.3.1.2.2. By Therapy
  • 6.3.2. Canada Maternal Mental Health Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Disease Indication
      • 6.3.2.2.2. By Therapy
  • 6.3.3. Mexico Maternal Mental Health Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Disease Indication
      • 6.3.3.2.2. By Therapy

7. Europe Maternal Mental Health Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Disease Indication
  • 7.2.2. By Therapy
  • 7.2.3. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Maternal Mental Health Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Disease Indication
      • 7.3.1.2.2. By Therapy
  • 7.3.2. United Kingdom Maternal Mental Health Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Disease Indication
      • 7.3.2.2.2. By Therapy
  • 7.3.3. Italy Maternal Mental Health Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecasty
      • 7.3.3.2.1. By Disease Indication
      • 7.3.3.2.2. By Therapy
  • 7.3.4. France Maternal Mental Health Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Disease Indication
      • 7.3.4.2.2. By Therapy
  • 7.3.5. Spain Maternal Mental Health Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Disease Indication
      • 7.3.5.2.2. By Therapy

8. Asia-Pacific Maternal Mental Health Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Disease Indication
  • 8.2.2. By Therapy
  • 8.2.3. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Maternal Mental Health Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Disease Indication
      • 8.3.1.2.2. By Therapy
  • 8.3.2. India Maternal Mental Health Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Disease Indication
      • 8.3.2.2.2. By Therapy
  • 8.3.3. Japan Maternal Mental Health Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Disease Indication
      • 8.3.3.2.2. By Therapy
  • 8.3.4. South Korea Maternal Mental Health Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Disease Indication
      • 8.3.4.2.2. By Therapy
  • 8.3.5. Australia Maternal Mental Health Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Disease Indication
      • 8.3.5.2.2. By Therapy

9. South America Maternal Mental Health Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Disease Indication
  • 9.2.2. By Therapy
  • 9.2.3. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Maternal Mental Health Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Disease Indication
      • 9.3.1.2.2. By Therapy
  • 9.3.2. Argentina Maternal Mental Health Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Disease Indication
      • 9.3.2.2.2. By Therapy
  • 9.3.3. Colombia Maternal Mental Health Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Disease Indication
      • 9.3.3.2.2. By Therapy

10. Middle East and Africa Maternal Mental Health Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Disease Indication
  • 10.2.2. By Therapy
  • 10.2.3. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Maternal Mental Health Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Disease Indication
      • 10.3.1.2.2. By Therapy
  • 10.3.2. Saudi Arabia Maternal Mental Health Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Disease Indication
      • 10.3.2.2.2. By Therapy
  • 10.3.3. UAE Maternal Mental Health Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Disease Indication
      • 10.3.3.2.2. By Therapy

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Merger & Acquisition
• 12.2. Product Development
• 12.3. Recent Developments

13. Global Maternal Mental Health Market: SWOT Analysis

14. Competitive Landscape

• 14.1. Therapy Mama
  • 14.1.1. Business Overview
  • 14.1.2. Application Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Key Personnel
  • 14.1.5. SWOT Analysis
• 14.2. Canopie
• 14.3. Pfizer Inc
• 14.4. Viatris Inc.
• 14.5. GlaxoSmithKline Inc.
• 14.6. Alembic Pharmaceuticals Limited
• 14.7. Mallinckrodt Inc.
• 14.8. Sage Therapeutics, Inc.
• 14.9. Bausch Health Companies Inc.
• 14.10. Magellan Health, Inc.

15. Strategic Recommendations

16. About Us & Disclaimer